Duration of untreated genital infections with chlamydia trachomatis: A review of the literature

Sexually Transmitted Diseases

Volumn 27, Issue 6, 2000, Pages 329-337

  Golden, Matthew R ^a,b   Schillinger, Julia A ^a   Markowitz, Lauri ^a   St Louis, Michael E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; GENITAL TRACT INFECTION; GUINEA PIG; HUMAN; INFECTION RISK; NONHUMAN; PATIENT COUNSELING;

EID: 0033935942     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200007000-00006     Document Type: Article

References (84)

1. McCormack WM, Alpert S, McComb DE, et al. Fifteen-month follow-up study of women with Chlamydia trachomatis. N Engl J Med 1979; 300:123-125.
2. Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implications for control. Med Clin North Am 1990; 74:1339-1352.
3. Groseclose SL, Zaidi AA, DeLisle SJ, Levine WC, St. Louis ME. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1998; 26:339-344.
4. Anderson RM, May RM. Epidemiologic parameters in HIV transmission. Nature 1988; 333:514-519.
5. Kretzschmar M, van Duynhoven YTHP, Severijnen AJ. Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations. Am J Epidemiol 1996; 144:306-317.
6. Stigum H, Magnus P, Bakketeig LS. Effect of changing partnership formation rates on the spread of sexually transmitted diseases and human immunodeficiency virus. Am J Epidemiol 1997; 145:644-652.
7. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58:686-699.
8. Barron AL, Rank RG, Moses EB. Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar). Infect Immun 1984; 44:82-85.
9. Morrison R, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995; 63:4661-4668.
10. Beale A. Does Chlamydia trachomatis MoPn enter a microbiologically-inapparent state during experimental infection of the mouse genital tract? Micro Path 1997; 22:99-112.
11. Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 1981; 12:111-115.
12. Tuffrey M, Falder P, Taylor-Robinson D. Genital-tract infection and disease in nude and immunologically competant mice after innoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol 1982; 63:539-546.
13. Tuffrey M, Falder P, Taylor-Robinson D. Reinfection of the mouse genital tract with Chlamydia trachomatis: the relationship of antibody to immunity. Br J Exp Pathol 1984; 65:51-58.
14. Rank RG, White HJ, Barron AL. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 1979; 26:573.
15. Pasley JN, White HJ, Barron AL. Persistent chronic active cervicitis: a newly noted finding in an animal model of chlamydial genital disease. J Infect Dis 1990; 162:1219-1220.
16. Johnson AP, Hetherington CM, Osborn MF, Thomas BJ, Taylor-Robinson D. Experimental infection of the marmoset genital tract with Chlamydia trachomatis. Br J Exp Pathol 1980; 61:291-295.
17. Johnson AP, Osbourn MF, Thomas BJ, Hetherington CM, Taylor-Robinson D. Immunity to reinfection of the genital tract of marmosets with Chlamydia trachomatis. Br J Exp Pathol 1981; 62:606-613.
18. Wolner-Hanssen P, Patton DL, Holmes KK. Protective immunity in pig-tail macaques after cervical infection with Chlamydia trachomatis. Sex Transm Dis 1991; 18:21-25.
19. Patterson TL, Rank RG. Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 1996; 23:145.
20. Gale JL, DiGiacomo RF, Kiviat MD, Wand SP, Bowie WR. Experimental nonhuman primate urethral infection with Chlamydia trachomatis and Ureaplasma (T-Mycoplasma). In: Hobson D, Holmes KK, eds. Nongonococcal Urethritis and Related Infections. Washington DC: American Society of Microbiology, 1977:205-213.
21. Digiacomo RF, Gale JL, Wang SP, Kiviat MD. Chlamydial infection of the male baboon urethra. Br J Vener Dis 1975; 51:310-313.
22. Jacobs NF, Arum ES, Kraus SJ. Experimental infection of the chimpanzee urethra and pharynx with Chlamydia trachomatis. Sex Transm Dis 1978; 5:132-136.
23. Cotter TW, Miranpuri GS, Ramsey KH, et al. Reactivation of chlamydial genital tract infection in mice. Infect Immun 1997; 65:2067-2073.
24. Ozanne G, Pearce JH. Inapparent chlamydial infection in the urogenital tract of guinea pigs. J Gen Microbiol 1980; 119:351-359.
25. Cappuccio AL, Patton DL, Kuo CC, Cambell LA. Detection of Chlamydia trachomatis deoxyribonucleic acid in monkey models (Macaca nemestrina) of salpingitis by in situ hybridization: implications for pathogenesis. Am J Obstet Gynecol 1994; 171:102-110.
26. Patton DL, Sweeney YC, Bohannon NJ, et al. Effects of doxycycline and antiinflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques. J Infect Dis 1997; 175:648-654.
27. Rank RG, Batteiger BE, Soderberg LSF. Susceptibility to reinfection after a primary chlamydial genital infection. Infect Immun 1988; 2243-2249.
28. Patterson T, Rank R. Immunity to reinfection and immunization of male guinea pigs against urethral infection with the agent of guinea pig inclusion conjunctivitis. Sex Transm Dis 1996; 23:145.
29. Schachter J, Hanna L, Hill EC, et al. Are chlamydial infections the most prevalent venereal disease? JAMA 1975; 231:1252-1255.
30. Alexander ER, Chandler J, Pheifer TA, et al. Prospective study of perinatal Chlamydia trachomatis infection. In: Hobson D, Holmes KK, eds. Nongonococcal Urethritis and Related Infections. Washington DC: American Society of Microbiology, 1977.
31. Paavonen J, Kousa M, Saikku P, et al. Treatment of nongonoccal urethritis with trimethoprim-sulfadiazine and with placebo: a double-blind partner-controlled study. Br J Vener Dis 1980; 56:101-104.
32. Rahm VA, Gnarpe H, Odlind V. Chlamydia trachomatis among sexually active teenage girls: lack of correlation between chlamydial infection, history of the patient and clinical signs of infection. Br J Obstet Gynecol 1988; 95:916-919.
33. Rahm VA, Belsheim J, Gleerup A, Gnarpe H, Rosen G. Asymptomatic carriage of Chlamydia trachomatis: a study of 109 girls. Eur J STD AIDS 1986; 3:91-94.
34. Sorensen JL, Thranov I, Hoff G, Dirach J. Early and Late-onset pelvic inflammatory disease among women with cervical Chlamydia trachomatis infection at the time of induced abortion: a follow-up study. Infection 1994; 22:242-246.
35. Parks KS, Dixin PB, Richey CM, Hook EW. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997; 24:229-235.
36. Schachter J, Cles LD, Ray RM, Hesse FE. Is there immunity to chlamydial infections in the human genital tract? Sex Transm Dis 1983; 10:123-125.
37. Katz BP, Batteiger BE, Jones RB. Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis 1987; 14:160-164.
38. Rees E. The treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980; 138:1042-1047.
39. Bowie WR, Willetts V, Megran DW. Dose-ranging study of Fleroxcin for treatment of uncomplicated Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 1989; 33:1774-1777.
40. Stenberg K, Mardh PA. Persistent neonatal chlamydial infection in a six year old girl. Lancet 1986; ii:1278-1279.
41. Hammerschlag MR, Doraiswamy B, Alexander ER, et al. Are rectogenital chlamydia infections a marker of sexual abuse in children? Pediatr Infect Dis 1984; 3:100-104.
42. Cambell LA, et al. Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil Steril 1993; 59:45-50.
43. Yung-Kuei S, Shu-Min K, Chang-Jen L, et al. Endocervical chlamydial deoxyribonucleic acid in infertile women. Fertil Steril 1990; 54:815-818.
44. Shepard MK, Jones RBJ. Recovery of Chlamydia trachomatis from endometrial fallopian tube biopsies in women with infertility of tubal origin. Fertil Steril 1989; 52:232-238.
45. Henry-Suchet J, Catalan F, Sanson MJ, et al. Chlamydia trachomatis associated with chronic inflammation in abdominal specimens from women selected for tuboplast. Fertil Steril 1981; 36:599-605.
46. Henry-Suchet J, Utzmann C, De Brux J, et al. Microbiologic study of chronic inflammation associated with tubal factor infertility: role of Chlamydia trachomatis. Fertil Steril 1987; 47:274-277.
47. Sellors JW, Mahony JB, Chernesky MA, Rath DJR. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. Fertil Steril 1988; 49:451-457.
48. Koeim M, Brunham RC. Fallopian tube obstruction as a sequela to Chlamydia trachomatis infection. Eur J Clin Microbiol 1986; 5:584-590.
49. Osser S, Persson K, Liedholm P. Tubal infertility and silent chlamydial salpingitis. Hum Reprod 1989; 4:280-284.
50. Moore DE, Foy HM, Daling JR, et al. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet 1999;2(8298):574-577.
51. Cleary RE, Jones RB. Recovery of Chlamydia trachomatis from the endometrium in infertile women with serum antichlamydial antibodies. Fertil Steril 1985; 44:233-235.
52. Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985; 152:1275-1282.
53. Kane JL, Woodland RM, Forsey T, Darougar S, Elder MG. Evidence of chlamydial infection in infertile women with and without fallopian tube obstruction. Fertil Steril 1984; 42:843-848.
54. Anestad G, Lunde O, Moen M, Dalaker K. Infertility and chlamydial infection. Fertil Steril 1987; 48:787-790.
55. Thejls H, Gnarpe J, Lundkvist O, et al. Diagnosis and prevalence of persistent chlamydial infection in infertile women: tissue culture, direct antigen detection, and serology. Fertil Steril 1991; 55:304-310.
56. Gaydos CA, Crotchfelt KA, Howell MR, et al. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998; 177:417-424.
57. Bianchi A, Bogard M, Cessot G, et al. Kinetics of Chlamydia trachomatis clearance in patients with azithromycin, as assessed by first void urine testing by PCR and transcription-mediated amplification. Sex Transm Dis 1998; 25:366-367.
58. Gerard HC, Branigan PJ, Balsara GR, Heath C, Minassian SS, Hudson AP. Viability of Chlamydia trachomatis in fallopian tubes of patients with ectopic pregnancy. Fertil Steril 1998; 70:945-948.
59. Gerard HC, Branigan PJ, Schumacher HR, Hudson AP. Synovial Chlamydia trachomatis in patients with reactive arthritis-Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 1998; 25:734-742.
60. Handsfield HH, Alexander ER, Wang SP, Pedersen HB, Holmes KK. Differences in the therapeutic responses of chlamydia-positive and chlamydia-negative forms of nongonococcal urethritis. J Am Vener Dis Assoc 1976; 2:5-9.
61. Prentice MJ, Taylor-Robinson D, Csonka GW. Non-specific urethritis: a placebo-controlled trial of minocycline in conjunction with laboratory investigations. Br J Vener Dis 1976; 52:269.
62. Terho P. Chlamydia trachomatis in non-specific urethritis. Br J Vener Dis 1978; 54:215-256.
63. Johannisson G, Sernryd A, Lycke E. Susceptibility of Chlamydia trachomatis to antibiotics in titro and in vivo. Sex Transm Dis 1979; 6:50-57.
64. Mclean KA, Evans BA, Lim JMH, Azadin BS. Postgonococcal urethritis: a double-blind study of doxycycline vs placebo. Genitourin Med 1990; 66:20-23.
65. Oriel JD, Reev P, Thomas BJ, Nicol CS. Infection with chlamydia group A in men with urethritis due to Neisseria gonorrhoeae. J Infect Dis 1975; 131:376-382.
66. Bowie WR, Alexander ER, Holmes KK. Etiologies of postgonococcal urethritis in homosexual and heterosexual men: roles of Chlamydia trachomatis and Ureaplasma urealyticum. Sex Transm Dis 1978; 5:151-154.
67. Hawkins DA, Taylor-Robinson D, Evans RT, Furr PM, Harris JR. Unsuccessful treatment of non-gonococcal urethritis with rosoxacin provides information on the aetiology of the disease. Genitourin Med 1985; 61:51-55.
68. Stamm W, Cole B. Asymptomatic Chlamydia trachomatis urethritis in men Sex Transm Dis 1986; 13:163-165.
69. Arya OP, Hobson D, Hart CA, Bartzokas C, Pratt BC. Evaluation of ciprofloxacin 500mg twice daily for one week in treating uncomplicated gonoococcal, chlamydial, and non-specific urethritis in men. Genitourin Med 1986; 62:170-174.
70. Fong IW, Linton W, Simul M, et al. Treatment of nongonococcal urethritis. Am J Med 1987; 82(suppl 4A):311-316.
71. Van der Willigen AH, Polak-Vogelzang AA, Habbema L, Wagenvoort JHT. Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males. Eur J Clin Microbiol Infect Dis 1988; 7:658-661.
72. Perea EJ, Aznar J, Herrera A, Mazuecos J, Rodriquez-Pichardo A. Clinical efficacy of new quinolones for therapy of nongonococcal urethritis. Sex Transm Dis 1989; 16:7-10.
73. Bowie WR, Willetts V, Megran DW. Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomaits genital infections. Antimicrob Agents Chemother 1989; 33:1774-1777.
74. Hooton TM, Rogers EM, Medina TG, et al. Ciprofloxicin compared with doxycycline for nongonococcal urethritis: ineffectiveness against Chlamydia trachomatis due to relapsing infection. JAMA 1990; 264:1418-1421.
75. Jones RB. Chlamydia trachomatis (Trachoma, perinatal infections, lymphogranuloma venereum, and other genital infections). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. 4th ed. New York: Churchill Livingston, 1995:1679-1693.
76. Blythe MJ, Katz B, Batteiger BE, Ganser JA, Jones RB. Recurrent genitourinary chlamydial infections in sexually active female adolescents. J Pediatr 1992; 121:487-493.
77. Dean D, Suchland R, Stamm W. Apparent long-term persistence of Chlamydia trachomatis cervical infections-analysis by OMP1 genotyping. In: Stephens RS, Byrne GI, Christiansen G, et al, eds. Chlamydial Infections: Proceedings of the Ninth International Symposium on Human Chlamydial Infection. 1998:31-34.
78. Katz BP, Fortenberry D, Orr D. Factors affecting chlamydial persistence or recurrence one and three months after treatment. In: Stephens RS, Byrne GI, Christiansen G, et al, eds. Chlamydial Infections: Proceedings of the Ninth International Symposium on Human Chlamydial Infection. 1998:35-38.
79. Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. JAMA 1993; 270:2071-2075.
80. Bell TA, Stamm WE, Wang SP, et al. Chronic Chlamydia trachomatis infections in infants. JAMA 1992; 267:400-402.
81. Dan M, Rotmensch HH, Eylan E, et al. A case of lymphogranuloma venereum of 20 years' duration. Br J Vener Dis 1980; 56:344-346.
82. Ormsby HL, Thompson GA, Cousineau GG, Lloyd LA, Hassard J. Topical therapy in inclusion conjunctivitis. Am J Opthalmol 1952; 35:1811-1814.
83. Hook EW III, Spitters C, Reichart CA, Neumann TM, Quinn TC. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272:867-870.
84. Schwebke JR, Sadler R, Sutton JM, Hook EW III. Positive screening tests for gonorrhea and chlamydial infections fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic. Sex Transm Dis 1997; 24:181-184.